Free Trial
→ I was wrong about Trump (From Porter & Company) (Ad) Free QURE Stock Alerts

uniQure (QURE) Financials

uniQure logo
$15.44 +1.02 (+7.04%)
As of 12:29 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for uniQure

Annual Income Statements for uniQure

This table shows uniQure's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 -50 -82 -73 -79 -83 -124 -125 330 -127 -308 -240
Consolidated Net Income / (Loss)		 -50 -82 -73 -79 -83 -124 -125 330 -127 -308 -240
Net Income / (Loss) Continuing Operations		 -50 -82 -73 -79 -83 -124 -125 330 -127 -308 -240
Total Pre-Tax Income 		-50 -83 -72 -79 -83 -124 -141 333 -128 -307 -237
Total Operating Income		 -54 -71 -72 -71 -88 -121 -125 311 -143 -283 -184
Total Gross Profit		 6.14 11 25 13 11 7.28 38 499 105 16 26
Total Revenue		 6.14 11 25 13 11 7.28 38 524 106 16 27
Operating Revenue		 6.14 11 25 13 11 7.28 38 524 106 16 27
Total Cost of Revenue		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 25 1.25 0.07 1.27
Operating Cost of Revenue		 - - - - - 0.00 0.00 25 1.25 0.07 1.27
Total Operating Expenses		 60 82 97 84 100 128 163 188 248 299 210
Selling, General & Admin Expense		 17 23 26 28 27 36 44 57 56 76 57
Research & Development Expense		 44 59 73 72 75 95 122 144 198 215 144
Other Operating Expenses / (Income)		 -1.02 -0.78 -1.47 -15 -2.15 -1.89 -3.34 -12 -5.08 7.50 9.13
Total Other Income / (Expense), net		 3.37 -12 -0.28 -8.12 5.16 -3.06 -16 22 15 -24 -53
Interest Expense		 2.02 2.57 2.17 2.23 2.16 3.81 3.83 7.47 12 42 64
Interest & Investment Income		 0.22 0.12 0.07 0.12 2.73 3.55 0.94 0.16 0.61 20 21
Other Income / (Expense), net		 5.17 -9.66 1.82 -6.00 4.59 -2.80 -13 30 26 -1.69 -11
Income Tax Expense		 -0.54 -1.18 1.15 -0.20 0.23 0.00 -16 3.22 -1.47 1.92 2.43
Basic Earnings per Share		 ($2.91) ($3.72) ($2.93) ($2,940.00) ($2,340.00) ($3.11) ($2.81) $7.17 ($2.71) ($6.47) ($4.92)
Weighted Average Basic Shares Outstanding		 17.12M 22.08M 25.04M 26.98M 35.64M 40.00M 44.47M 45.99M 46.74M 47.67M 48.65M
Diluted Earnings per Share		 ($2.91) ($3.72) ($2.93) ($2,940.00) ($2,340.00) ($3.11) ($2.81) $7.04 ($2.71) ($6.47) ($4.92)
Weighted Average Diluted Shares Outstanding		 17.12M 22.08M 25.04M 26.98M 35.64M 40.00M 44.47M 46.84M 46.74M 47.67M 48.65M
Weighted Average Basic & Diluted Shares Outstanding		 17.12M 22.08M 25.04M 26.98M 35.64M 40.00M 44.47M 46.46M 46.98M 47.84M 54.08M

Quarterly Income Statements for uniQure

This table shows uniQure's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -48 6.81 -77 -68 -90 -73 -66 -56 -44 -73 -44
Consolidated Net Income / (Loss)		 -48 6.81 -77 -68 -90 -73 -66 -56 -44 -73 -44
Net Income / (Loss) Continuing Operations		 -48 6.81 -77 -68 -90 -73 -66 -56 -44 -73 -44
Total Pre-Tax Income 		-48 6.60 -78 -68 -90 -70 -65 -55 -44 -72 -43
Total Operating Income		 -60 27 -74 -65 -82 -62 -54 -44 -40 -46 -39
Total Gross Profit		 1.45 101 5.33 2.42 1.41 6.62 8.34 11 2.02 4.60 1.37
Total Revenue		 1.45 103 5.33 2.42 1.41 6.69 8.49 11 2.29 5.22 1.57
Operating Revenue		 1.45 103 5.33 2.42 1.41 6.69 8.49 11 2.29 5.22 1.57
Total Cost of Revenue		 0.00 1.25 0.00 0.00 0.00 0.07 0.15 0.23 0.26 0.62 0.20
Operating Cost of Revenue		 - - 0.00 0.00 0.00 0.07 0.15 0.23 0.26 0.62 0.20
Total Operating Expenses		 61 75 79 67 83 68 63 55 42 50 41
Selling, General & Admin Expense		 14 18 18 21 18 19 14 16 13 14 13
Research & Development Expense		 48 58 61 46 65 43 41 34 31 39 36
Other Operating Expenses / (Income)		 -0.62 -1.79 0.62 0.05 -0.42 7.25 7.70 5.24 -1.83 -1.98 -8.31
Total Other Income / (Expense), net		 11 -20 -4.26 -3.24 -7.76 -8.42 -11 -11 -4.18 -27 -3.81
Interest Expense		 3.07 3.43 3.56 6.84 15 16 16 16 17 15 15
Interest & Investment Income		 0.04 0.49 1.67 3.23 7.50 7.17 6.51 5.81 4.87 4.24 4.13
Other Income / (Expense), net		 14 -17 -2.37 0.37 0.19 0.12 -1.15 -0.99 7.56 -16 7.17
Income Tax Expense		 -0.33 -0.21 -1.21 0.16 -0.07 3.03 0.66 0.95 -0.03 0.86 0.50
Basic Earnings per Share		 ($1.02) $0.15 ($1.63) ($1.44) ($1.88) ($1.52) ($1.36) ($1.16) ($0.91) ($1.49) ($0.82)
Weighted Average Basic Shares Outstanding		 46.77M 46.74M 47.44M 47.65M 47.77M 47.67M 48.38M 48.62M 48.72M 48.65M 53.11M
Diluted Earnings per Share		 ($1.02) $0.15 ($1.63) ($1.44) ($1.88) ($1.52) ($1.36) ($1.16) ($0.91) ($1.49) ($0.82)
Weighted Average Diluted Shares Outstanding		 46.77M 46.74M 47.44M 47.65M 47.77M 47.67M 48.38M 48.62M 48.72M 48.65M 53.11M
Weighted Average Basic & Diluted Shares Outstanding		 46.82M 46.98M 47.58M 47.70M 47.81M 47.84M 48.55M 48.70M 48.74M 54.08M 54.75M

Annual Cash Flow Statements for uniQure

This table details how cash moves in and out of uniQure's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 32 160 -87 19 78 143 -133 312 -328 13 -84
Net Cash From Operating Activities		 -37 7.47 -72 -64 -76 -99 -135 288 -145 -146 -183
Net Cash From Continuing Operating Activities		 -37 7.47 -72 -64 -76 -99 -135 289 -145 -145 -183
Net Income / (Loss) Continuing Operations		 -50 -82 -73 -79 -83 -124 -125 330 -127 -308 -240
Consolidated Net Income / (Loss)		 -50 -82 -73 -79 -83 -124 -125 330 -127 -308 -240
Depreciation Expense		 2.58 6.32 6.09 7.54 12 6.67 11 7.30 8.54 12 13
Amortization Expense		 - - - - - - - 0.00 0.00 -11 -11
Non-Cash Adjustments To Reconcile Net Income		 8.95 8.83 0.19 26 6.45 21 36 -57 -27 179 76
Changes in Operating Assets and Liabilities, net		 1.40 74 -5.10 -19 -12 -2.11 -57 8.48 0.15 -16 -21
Net Cash From Investing Activities		 -24 -8.02 -17 -5.58 -4.25 -6.65 -9.48 -67 -183 -206 163
Net Cash From Continuing Investing Activities		 -24 -8.02 -17 -5.58 -4.25 -6.65 -9.48 -67 -183 -206 163
Purchase of Property, Plant & Equipment		 -22 -7.61 -15 -4.46 -2.38 -5.65 -7.27 -17 -18 -7.15 -3.37
Acquisitions		 -1.75 -0.42 -1.88 -1.12 -1.86 -1.00 -2.21 -50 -1.90 0.00 0.00
Purchase of Investments		 - - - - - - 0.00 0.00 -163 -366 -360
Sale and/or Maturity of Investments		 - - - - - - - 0.00 0.00 168 534
Other Investing Activities, net		 - - - - - - - - 0.00 0.00 -8.32
Net Cash From Financing Activities		 94 161 2.45 90 158 249 7.44 95 1.45 363 -59
Net Cash From Continuing Financing Activities		 94 161 2.45 89 158 249 7.44 95 1.45 363 -59
Repayment of Debt		 - - -0.15 - - 0.00 0.00 -1.57 0.00 -4.29 -53
Issuance of Common Equity		 85 85 2.59 89 143 248 7.44 34 1.45 0.31 2.12
Other Financing Activities, net		 - - - 0.58 0.00 0.50 - 0.00 0.00 367 -8.56
Effect of Exchange Rate Changes		 -1.69 - - - - -0.11 3.82 -3.76 -1.83 2.27 -4.97
Cash Interest Paid		 1.63 2.08 2.35 1.62 2.14 3.12 4.13 6.54 9.25 17 21

Quarterly Cash Flow Statements for uniQure

This table details how cash moves in and out of uniQure's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Change in Cash & Equivalents		 -60 -212 -74 360 -284 12 1.69 45 -38 -93 58
Net Cash From Operating Activities		 -49 -55 -78 -57 39 -50 -61 -33 -37 -53 -44
Net Cash From Continuing Operating Activities		 -49 -55 -78 -57 39 -48 -61 -33 -37 -53 -44
Net Income / (Loss) Continuing Operations		 -48 6.81 -77 -68 -90 -73 -66 -56 -44 -73 -44
Consolidated Net Income / (Loss)		 -48 6.81 -77 -68 -90 -73 -66 -56 -44 -73 -44
Depreciation Expense		 2.10 2.33 2.53 2.59 2.60 4.19 2.63 2.67 2.99 4.36 4.53
Amortization Expense		 - - -0.93 -0.91 -4.69 -4.39 -3.70 -2.98 -1.80 -2.43 -2.12
Non-Cash Adjustments To Reconcile Net Income		 -3.61 -61 9.71 12 26 131 22 26 3.92 23 1.69
Changes in Operating Assets and Liabilities, net		 0.37 -2.68 -12 -2.55 104 -106 -16 -1.76 2.67 -4.43 -4.57
Net Cash From Investing Activities		 -5.06 -168 2.99 46 -314 60 64 78 48 -27 20
Net Cash From Continuing Investing Activities		 -5.06 -168 2.99 46 -314 60 64 78 48 -27 20
Purchase of Property, Plant & Equipment		 -3.99 -5.07 -2.34 -1.07 -1.70 -2.04 -2.34 -0.60 -0.38 -0.04 -0.13
Purchase of Investments		 - -163 0.00 - -366 - -84 -69 -127 -80 -65
Sale and/or Maturity of Investments		 - - 5.33 47 54 62 150 148 183 54 85
Net Cash From Financing Activities		 0.30 0.60 0.13 370 -7.59 0.05 0.00 0.05 -53 -6.52 81
Net Cash From Continuing Financing Activities		 0.30 0.60 0.13 370 -7.59 0.05 0.00 0.05 -53 -6.52 81
Issuance of Common Equity		 0.30 0.60 0.13 0.08 0.06 0.05 0.00 0.05 0.03 2.04 0.16
Other Financing Activities, net		 - - - - -7.65 - 0.00 - - -8.56 81
Effect of Exchange Rate Changes		 -6.49 10 1.03 0.78 -1.39 1.84 -1.73 -0.47 3.99 -6.77 1.66
Cash Interest Paid		 2.43 2.84 3.06 5.83 4.11 3.88 4.76 4.50 7.63 3.68 6.49

Annual Balance Sheets for uniQure

This table presents uniQure's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 263 190 210 274 449 340 809 705 832 557
Total Current Assets		 228 144 163 237 384 259 628 477 652 390
Cash & Equivalents		 222 132 159 235 378 245 556 228 241 159
Short-Term Investments		 - - - - - - 0.00 125 377 209
Accounts Receivable		 4.13 9.18 1.59 0.23 0.95 6.62 59 102 4.19 5.88
Prepaid Expenses		 0.69 1.00 1.14 1.12 4.72 4.34 11 12 15 9.28
Other Current Assets		 1.19 1.27 0.69 0.33 0.75 3.02 2.68 2.81 2.66 7.61
Plant, Property, & Equipment, net		 26 36 34 29 29 32 44 51 47 20
Total Noncurrent Assets		 8.54 11 13 8.15 36 49 137 178 133 146
Long-Term Investments		 - - - - - - 0.00 40 2.18 27
Goodwill		 0.48 0.47 0.53 0.51 0.50 0.54 28 26 26 22
Intangible Assets		 6.82 8.32 9.57 5.20 5.43 3.36 63 59 60 71
Noncurrent Deferred & Refundable Income Taxes		 - - - - 0.00 16 16 15 12 9.86
Other Noncurrent Operating Assets		 1.24 1.83 2.48 2.44 30 29 31 39 32 15
Total Liabilities & Shareholders' Equity		 263 190 210 274 449 340 809 705 832 557
Total Liabilities		 135 127 120 94 126 96 213 229 624 563
Total Current Liabilities		 27 23 19 20 32 27 37 76 74 40
Accounts Payable		 4.06 5.52 2.91 3.79 5.68 3.77 2.50 11 6.59 7.23
Accrued Expenses		 9.86 9.77 8.84 8.23 12 18 28 31 31 29
Other Current Liabilities		 - - - 7.63 5.87 5.52 5.77 8.38 8.34 3.60
Total Noncurrent Liabilities		 108 104 101 74 94 69 177 153 550 523
Long-Term Debt		 15 20 20 35 36 36 101 103 102 51
Noncurrent Deferred & Payable Income Tax Liabilities		 - - - - - 0.00 13 8.26 7.54 7.04
Other Noncurrent Operating Liabilities		 3.50 1.89 4.79 1.24 35 34 63 42 441 465
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 128 64 89 180 323 244 596 476 208 -6.75
Total Preferred & Common Equity		 128 64 89 180 323 244 596 476 208 -6.75
Total Common Equity		 128 64 89 180 323 244 596 476 208 -6.75
Common Stock		 457 466 568 722 989 1,019 1,080 1,116 1,152 1,176
Retained Earnings		 -323 -396 -475 -536 -660 -785 -455 -582 -890 -1,130
Accumulated Other Comprehensive Income / (Loss)		 -6.83 -6.56 -3.80 -7.26 -6.69 9.91 -29 -58 -54 -53

Quarterly Balance Sheets for uniQure

This table presents uniQure's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2022 Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025
Period end date 6/30/2022 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025
Total Assets		 701 638 631 943 872 770 731 646 605
Total Current Assets		 523 465 443 757 694 596 592 464 435
Cash & Equivalents		 501 440 154 514 229 243 288 252 217
Short-Term Investments		 - - 161 115 429 313 237 184 192
Accounts Receivable		 3.12 3.60 105 103 1.64 11 7.85 5.32 2.52
Prepaid Expenses		 15 14 13 12 15 19 18 19 13
Other Current Assets		 1.58 2.89 2.47 3.25 2.53 3.09 3.45 4.29 10
Plant, Property, & Equipment, net		 46 48 50 49 46 45 26 26 18
Total Noncurrent Assets		 132 126 138 137 132 129 113 156 152
Long-Term Investments		 - - 0.00 0.00 0.00 - - 28 28
Goodwill		 25 23 26 26 25 26 23 24 23
Intangible Assets		 57 54 60 60 58 59 59 77 72
Noncurrent Deferred & Refundable Income Taxes		 15 15 14 14 12 12 11 11 9.39
Other Noncurrent Operating Assets		 34 34 38 38 36 33 20 16 19
Total Liabilities & Shareholders' Equity		 701 638 631 943 872 770 731 646 605
Total Liabilities		 215 217 218 589 603 623 634 590 572
Total Current Liabilities		 48 64 66 68 69 63 80 71 36
Accounts Payable		 10 7.57 8.89 9.37 5.58 5.23 4.41 5.44 5.27
Accrued Expenses		 23 26 23 24 28 23 26 32 27
Other Current Liabilities		 6.51 6.43 7.67 7.78 7.89 8.00 3.63 4.30 3.70
Total Noncurrent Liabilities		 166 153 152 521 534 560 553 519 535
Long-Term Debt		 102 102 103 101 101 102 103 51 52
Noncurrent Deferred & Payable Income Tax Liabilities		 9.95 8.59 6.97 6.80 4.92 7.38 7.32 7.63 7.34
Other Noncurrent Operating Liabilities		 55 42 42 413 428 450 443 460 476
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 486 421 413 353 269 147 97 56 34
Total Preferred & Common Equity		 486 421 413 353 269 147 97 56 34
Total Common Equity		 486 421 413 353 269 147 97 56 34
Common Stock		 1,095 1,103 1,124 1,133 1,145 1,159 1,166 1,169 1,261
Retained Earnings		 -541 -589 -659 -728 -817 -956 -1,012 -1,057 -1,174
Accumulated Other Comprehensive Income / (Loss)		 -68 -93 -52 -52 -59 -56 -56 -57 -54

Annual Metrics And Ratios for uniQure

This table displays calculated financial ratios and metrics derived from uniQure's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 72.25% 137.27% -47.78% -13.91% -35.48% 415.23% 1,296.82% -79.68% -85.12% 71.17%
EBITDA Growth		 0.00% -62.16% 14.03% -9.00% -2.04% -64.64% -9.07% 371.61% -131.27% -161.06% 31.92%
EBIT Growth		 0.00% -66.58% 13.22% -10.29% -8.14% -48.18% -11.79% 345.47% -134.45% -142.87% 31.54%
NOPAT Growth		 0.00% -32.54% -1.12% 0.84% -23.67% -37.30% -3.54% 450.37% -132.58% -97.59% 34.85%
Net Income Growth		 0.00% -64.90% 10.61% -8.02% -5.10% -49.09% -0.66% 363.62% -138.47% -143.30% 22.34%
EPS Growth		 0.00% -27.84% 21.24% -100,241.30% 20.41% 99.87% 9.65% 350.53% -138.49% -138.75% 23.96%
Operating Cash Flow Growth		 0.00% 120.27% -1,066.64% 10.97% -18.31% -29.78% -36.63% 313.58% -150.38% -0.60% -25.22%
Free Cash Flow Firm Growth		 0.00% 0.00% -417.62% 32.96% -78.61% 4.59% -64.13% 243.00% -185.11% 272.64% -120.59%
Invested Capital Growth		 0.00% 0.00% 33.83% 1.01% 58.82% 5.79% 285.24% 306.14% 50.88% -233.26% -24.07%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% -33.31% -7.96% 16.24% 485.15% 4.79% 73.34% -85.84% -5.14%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% -23.67% 6.70% -20.61% 17.07% 7.98% 0.08% -35.11% 1.02%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% -20.80% 5.27% -19.02% 15.69% 8.32% -0.33% -33.35% -0.07%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% -9.61% -1.80% -7.81% 16.46% -1.67% 14.58% -45.34% 7.95%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% -19.17% 6.28% -18.67% 37.92% -7.51% -1.12% -35.02% -0.02%
EPS Q/Q Growth		 0.00% 0.00% 0.00% -112,543.68% 42.91% 99.74% 25.27% 3.53% -3.04% -34.79% 0.61%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% -3.83% 0.06% -8.83% -9.03% -3.33% -5.52% 3.40% -1.84%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% -0.75% -6.58% -33.08% -5.27% -22.35% 27.46% 18.41%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% -0.86% -4.40% -9.82% 314.76% 67.68% 98.48% -7.81% -7.05%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 95.23% 98.82% 99.59% 95.33%
EBITDA Margin		 -747.97% -704.17% -255.15% -532.55% -631.22% -1,610.62% -340.96% 66.30% -102.01% -1,789.93% -711.90%
Operating Margin		 -874.16% -672.63% -286.66% -544.31% -781.92% -1,663.78% -334.34% 59.28% -134.44% -1,785.46% -679.58%
EBIT Margin		 -789.99% -763.95% -279.41% -590.10% -741.24% -1,702.21% -369.34% 64.91% -110.03% -1,796.14% -718.32%
Profit (Net Income) Margin		 -810.57% -775.98% -292.35% -604.72% -738.25% -1,705.82% -333.27% 62.90% -119.07% -1,947.09% -883.35%
Tax Burden Percent		 98.94% 98.58% 101.59% 99.75% 100.28% 100.00% 88.39% 99.03% 98.85% 100.63% 101.02%
Interest Burden Percent		 103.71% 103.03% 103.00% 102.73% 99.32% 100.21% 102.08% 97.85% 109.47% 107.73% 121.73%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.97% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -1,103.20% 351.41% -56.87% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -1,089.69% 344.80% -49.48% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1,059.10% -272.91% 33.21% 0.00% 0.00%
Return on Equity (ROE)		 0.00% -64.16% -76.61% -103.61% -61.94% -49.42% -44.10% 78.50% -23.66% -90.24% -238.46%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -407.81% 230.44% -97.43% 0.00% 0.00%
Operating Return on Assets (OROA)		 0.00% -30.77% -30.97% -38.68% -34.60% -34.31% -35.12% 59.17% -15.48% -37.04% -28.06%
Return on Assets (ROA)		 0.00% -31.25% -32.40% -39.64% -34.46% -34.38% -31.69% 57.34% -16.75% -40.15% -34.51%
Return on Common Equity (ROCE)		 0.00% -64.16% -76.61% -103.61% -61.94% -49.42% -44.10% 78.50% -23.66% -90.24% -238.46%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -64.16% -115.31% -88.70% -46.38% -38.45% -51.26% 55.32% -26.64% -148.54% 3,547.93%
Net Operating Profit after Tax (NOPAT)		 -38 -50 -50 -50 -62 -85 -88 308 -100 -198 -129
NOPAT Margin		 -611.91% -470.84% -200.66% -381.02% -547.34% -1,164.65% -234.04% 58.71% -94.11% -1,249.82% -475.70%
Net Nonoperating Expense Percent (NNEP)		 0.00% -32.05% -14.67% -23.48% -12.79% -14.56% -13.51% 6.61% -7.39% -29.30% -26.52%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - -16.57% -58.65% -289.43%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 4.77% 1.18% 0.41% 4.67%
SG&A Expenses to Revenue		 278.02% 221.05% 103.59% 211.40% 237.97% 488.56% 116.98% 10.91% 52.48% 481.48% 211.03%
R&D to Revenue		 712.78% 558.94% 288.91% 550.64% 662.97% 1,301.15% 326.28% 27.39% 185.56% 1,356.21% 530.19%
Operating Expenses to Revenue		 974.16% 772.63% 386.66% 644.31% 881.92% 1,763.78% 434.34% 35.96% 233.27% 1,885.05% 774.90%
Earnings before Interest and Taxes (EBIT)		 -49 -81 -70 -77 -84 -124 -139 340 -117 -285 -195
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -46 -74 -64 -70 -71 -117 -128 347 -109 -284 -193
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 6.75 5.98 9.68 6.59 1.61 2.23 1.56 0.00
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 7.61 6.18 9.86 6.70 1.90 2.71 2.68 0.00
Price to Revenue (P/Rev)		 0.00 0.00 0.00 46.03 95.21 429.31 42.85 1.83 9.97 20.43 31.74
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.91 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 34.39% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 40.43 3.58 3.76 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 35.54 77.54 382.38 37.27 0.96 7.49 0.00 19.07
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.45 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.48 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.64 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.75 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.49 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.16 0.32 0.24 0.20 0.11 0.15 0.17 0.27 0.63 -7.60
Long-Term Debt to Equity		 0.00 0.11 0.31 0.22 0.20 0.11 0.15 0.17 0.22 0.49 -7.60
Financial Leverage		 0.00 -1.57 -1.64 -1.63 -1.25 -1.08 -0.97 -0.79 -0.67 -1.10 -4.15
Leverage Ratio		 0.00 2.05 2.36 2.61 1.80 1.44 1.39 1.37 1.41 2.25 6.91
Compound Leverage Factor		 0.00 2.12 2.44 2.69 1.79 1.44 1.42 1.34 1.55 2.42 8.41
Debt to Total Capital		 0.00% 13.64% 24.13% 19.67% 16.49% 10.04% 12.74% 14.49% 21.29% 38.49% 115.15%
Short-Term Debt to Total Capital		 0.00% 3.77% 0.72% 1.92% 0.00% 0.00% 0.00% 0.00% 4.30% 8.36% 0.00%
Long-Term Debt to Total Capital		 0.00% 9.88% 23.41% 17.75% 16.49% 10.04% 12.74% 14.49% 17.00% 30.14% 115.15%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 86.36% 75.87% 80.33% 83.51% 89.96% 87.26% 85.51% 78.71% 61.51% -15.15%
Debt to EBITDA		 0.00 -0.27 -0.32 -0.31 -0.50 -0.31 -0.28 0.29 -1.19 -0.46 -0.27
Net Debt to EBITDA		 0.00 2.70 1.75 1.97 2.80 2.91 1.64 -1.31 2.43 1.73 1.78
Long-Term Debt to EBITDA		 0.00 -0.20 -0.31 -0.28 -0.50 -0.31 -0.28 0.29 -0.95 -0.36 -0.27
Debt to NOPAT		 0.00 -0.41 -0.40 -0.44 -0.57 -0.43 -0.41 0.33 -1.29 -0.66 -0.40
Net Debt to NOPAT		 0.00 4.04 2.23 2.75 3.23 4.03 2.38 -1.48 2.64 2.48 2.66
Long-Term Debt to NOPAT		 0.00 -0.29 -0.39 -0.40 -0.57 -0.43 -0.41 0.33 -1.03 -0.51 -0.40
Altman Z-Score		 0.00 0.00 0.00 -0.50 4.08 12.92 6.35 4.82 1.91 -1.46 -2.28
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.00 8.48 6.34 8.47 11.85 12.15 9.47 17.09 6.28 8.85 9.74
Quick Ratio		 0.00 8.39 6.24 8.37 11.77 11.97 9.20 16.73 6.00 8.44 9.32
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 24 -75 -50 -90 -86 -141 202 -172 296 -61
Operating Cash Flow to CapEx		 -166.03% 98.17% -472.19% -1,440.71% -3,189.47% -1,746.31% -1,854.33% 1,651.33% -820.10% -2,039.82% -5,425.42%
Free Cash Flow to Firm to Interest Expense		 0.00 9.21 -34.63 -22.60 -41.70 -22.56 -36.88 26.99 -14.67 7.13 -0.96
Operating Cash Flow to Interest Expense		 -18.25 2.90 -33.24 -28.79 -35.20 -25.90 -35.25 38.53 -12.39 -3.51 -2.87
Operating Cash Flow Less CapEx to Interest Expense		 -29.25 -0.05 -40.27 -30.79 -36.31 -27.38 -37.15 36.19 -13.91 -3.68 -2.92
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.04 0.11 0.07 0.05 0.02 0.10 0.91 0.14 0.02 0.04
Accounts Receivable Turnover		 0.00 2.56 3.77 2.43 12.41 12.34 9.92 16.03 1.32 0.30 5.38
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00
Fixed Asset Turnover		 0.00 0.41 0.81 0.37 0.36 0.25 1.23 13.82 2.26 0.33 0.81
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.96 0.19 0.01 0.18
Days Sales Outstanding (DSO)		 0.00 142.47 96.78 149.90 29.42 29.58 36.80 22.77 276.18 1,227.60 67.79
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 53,200.15 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 45.84 1,962.68 49,331.15 1,989.64
Cash Conversion Cycle (CCC)		 0.00 142.47 96.78 149.90 29.42 29.58 36.80 -23.07 -1,686.49 5,096.60 -1,921.84
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 0.00 -73 -49 -48 -20 -19 35 140 212 -282 -350
Invested Capital Turnover		 0.00 -0.29 -0.41 -0.27 -0.33 -0.38 4.71 5.99 0.60 -0.45 -0.09
Increase / (Decrease) in Invested Capital		 0.00 -73 25 0.49 28 1.15 53 106 71 -494 -68
Enterprise Value (EV)		 0.00 0.00 0.00 466 875 2,784 1,398 503 797 -166 517
Market Capitalization		 0.00 0.00 0.00 603 1,074 3,126 1,608 958 1,061 324 861
Book Value per Share		 $0.00 $5.79 $2.54 $2.90 $4.82 $7.41 $5.48 $12.89 $10.17 $4.34 ($0.14)
Tangible Book Value per Share		 $0.00 $5.46 $2.19 $2.57 $4.66 $7.27 $5.39 $10.94 $8.37 $2.53 ($2.06)
Total Capital		 0.00 148 84 111 215 359 280 697 605 338 45
Total Debt		 0.00 20 20 22 35 36 36 101 129 130 51
Total Long-Term Debt		 0.00 15 20 20 35 36 36 101 103 102 51
Net Debt		 0.00 -201 -112 -137 -199 -342 -209 -455 -264 -490 -344
Capital Expenditures (CapEx)		 22 7.61 15 4.46 2.38 5.65 7.27 17 18 7.15 3.37
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 -15 -11 -14 -18 -25 -13 35 74 -12 -17
Debt-free Net Working Capital (DFNWC)		 0.00 207 122 146 217 353 232 591 427 606 350
Net Working Capital (NWC)		 0.00 201 121 144 217 353 232 591 401 578 350
Net Nonoperating Expense (NNE)		 12 32 23 29 22 39 37 -22 27 110 111
Net Nonoperating Obligations (NNO)		 0.00 -201 -112 -137 -199 -342 -209 -455 -264 -490 -344
Total Depreciation and Amortization (D&A)		 2.58 6.32 6.09 7.54 12 6.67 11 7.30 8.54 0.98 1.74
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% -140.32% -42.50% -104.40% -162.10% -346.34% -35.60% 6.72% 69.49% -72.61% -63.74%
Debt-free Net Working Capital to Revenue		 0.00% 1,954.84% 485.42% 1,111.52% 1,919.59% 4,842.41% 617.31% 112.88% 400.85% 3,827.49% 1,291.48%
Net Working Capital to Revenue		 0.00% 1,902.10% 483.01% 1,095.24% 1,919.59% 4,842.41% 617.31% 112.88% 376.45% 3,649.42% 1,291.48%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($2.91) ($3.72) ($2.93) ($2.94) ($2.34) ($3,110.00) ($2,810.00) $7.17 ($2.71) ($6.47) ($4.92)
Adjusted Weighted Average Basic Shares Outstanding		 17.12M 22.08M 25.45M 31.68M 37.63M 44.25M 44.99M 45.99M 46.74M 47.67M 48.65M
Adjusted Diluted Earnings per Share		 ($2.91) ($3.72) ($2.93) ($2.94) ($2.34) ($3,110.00) ($2,810.00) $7.04 ($2.71) ($6.47) ($4.92)
Adjusted Weighted Average Diluted Shares Outstanding		 17.12M 22.08M 25.45M 31.68M 37.63M 44.25M 44.99M 46.84M 46.74M 47.67M 48.65M
Adjusted Basic & Diluted Earnings per Share		 ($2.91) ($3.72) ($2.93) ($2.94) ($2.34) ($3,110.00) ($2,810.00) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 17.12M 22.08M 25.04M 26.98M 35.64M 40.00M 44.47M 46.46M 46.98M 47.84M 54.08M
Normalized Net Operating Profit after Tax (NOPAT)		 -38 -50 -50 -50 -62 -85 -88 308 -100 -198 -129
Normalized NOPAT Margin		 -611.91% -470.84% -200.66% -381.02% -547.34% -1,164.65% -234.04% 58.71% -94.11% -1,249.82% -475.70%
Pre Tax Income Margin		 -819.28% -787.12% -287.79% -606.23% -736.20% -1,705.82% -377.04% 63.51% -120.45% -1,934.97% -874.39%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -24.03 -31.42 -32.29 -34.65 -38.72 -32.53 -36.22 45.51 -10.01 -6.85 -3.06
NOPAT to Interest Expense		 -18.61 -19.36 -23.19 -22.37 -28.59 -22.26 -22.95 41.16 -8.56 -4.76 -2.02
EBIT Less CapEx to Interest Expense		 -35.02 -34.38 -39.33 -36.65 -39.83 -34.01 -38.12 43.17 -11.52 -7.02 -3.11
NOPAT Less CapEx to Interest Expense		 -29.61 -22.32 -30.23 -24.37 -29.70 -23.74 -24.85 38.82 -10.07 -4.94 -2.08
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.40% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for uniQure

This table displays calculated financial ratios and metrics derived from uniQure's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -27.15% 78.10% 197.15% 387.32% -2.90% -93.49% 59.34% 359.37% 62.54% -21.95% -81.53%
EBITDA Growth		 -31.32% 0.76% -75.51% -81.42% -94.61% -621.16% 24.69% 28.11% 62.43% 3.22% 47.29%
EBIT Growth		 -30.64% -3.93% -70.77% -76.20% -80.91% -746.49% 27.66% 30.45% 60.02% -0.22% 41.92%
NOPAT Growth		 -32.26% 1,166.39% -37.15% -16.08% -37.57% -258.15% 26.89% 32.37% 50.87% 25.78% 27.47%
Net Income Growth		 -31.00% -17.07% -65.45% -75.30% -87.16% -1,175.45% 15.03% 17.78% 50.45% -0.08% 33.50%
EPS Growth		 -29.11% -34.78% -63.00% -71.43% -84.31% -1,113.33% 16.56% 19.44% 51.60% 1.97% 39.71%
Operating Cash Flow Growth		 -22.00% -16.12% -204.55% -263.55% 179.42% 9.40% 22.64% 42.61% -194.06% -6.67% 27.20%
Free Cash Flow Firm Growth		 50.78% 57.45% -13.05% 281.64% 581.62% 1,122.12% 416.51% -29.34% -88.06% -92.04% -90.36%
Invested Capital Growth		 27.46% 50.88% 73.18% -251.75% -345.34% -233.26% -222.50% -116.28% -24.94% -24.07% -26.07%
Revenue Q/Q Growth		 191.55% 6,990.75% -94.82% -54.52% -41.91% 375.41% 26.85% 31.13% -79.44% 128.29% -69.99%
EBITDA Q/Q Growth		 -23.93% 127.56% -731.65% 15.90% -32.94% 26.20% 8.72% 19.73% 30.52% -90.09% 50.28%
EBIT Q/Q Growth		 -22.97% 121.11% -902.91% 15.47% -26.26% 24.56% 10.15% 18.73% 27.41% -89.09% 47.93%
NOPAT Q/Q Growth		 -6.17% 165.60% -289.97% 12.27% -25.82% 24.58% 12.18% 18.84% 8.59% -13.92% 14.18%
Net Income Q/Q Growth		 -22.52% 114.22% -1,234.52% 11.33% -30.81% 18.27% 10.37% 14.20% 21.17% -65.08% 40.44%
EPS Q/Q Growth		 -21.43% 114.71% -1,186.67% 11.66% -30.56% 19.15% 10.53% 14.71% 21.55% -63.74% 44.97%
Operating Cash Flow Q/Q Growth		 -212.48% -11.61% -43.20% 27.21% 168.27% -227.32% -22.27% 46.00% -11.88% -44.39% 16.55%
Free Cash Flow Firm Q/Q Growth		 40.52% 31.74% -235.84% 233.21% 57.72% 44.86% 4.50% -70.26% -73.35% -3.48% 26.08%
Invested Capital Q/Q Growth		 10.62% 98.48% 7.54% -164.27% -78.84% -7.81% 0.37% -13.47% -3.31% -7.05% -0.45%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 100.00% 98.78% 100.00% 100.00% 100.00% 99.03% 98.23% 97.90% 88.46% 88.14% 87.43%
EBITDA Margin		 -2,971.22% 11.55% -1,407.31% -2,602.15% -5,954.94% -924.35% -665.16% -407.21% -1,376.39% -1,146.10% -1,898.47%
Operating Margin		 -4,107.52% 25.79% -1,392.90% -2,686.79% -5,819.26% -923.13% -639.10% -395.56% -1,758.99% -877.76% -2,509.96%
EBIT Margin		 -3,116.36% 9.28% -1,437.39% -2,671.35% -5,806.04% -921.36% -652.60% -404.45% -1,428.25% -1,183.01% -2,052.27%
Profit (Net Income) Margin		 -3,302.76% 6.63% -1,450.27% -2,827.17% -6,366.10% -1,094.42% -773.34% -506.01% -1,940.45% -1,403.20% -2,784.75%
Tax Burden Percent		 99.32% 103.14% 98.46% 100.24% 99.92% 104.32% 101.01% 101.71% 99.93% 101.18% 101.15%
Interest Burden Percent		 106.71% 69.23% 102.47% 105.58% 109.73% 113.86% 117.32% 123.01% 135.96% 117.23% 134.15%
Effective Tax Rate		 0.00% -3.14% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -1,853.66% 16.07% -596.67% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 -1,852.15% 21.78% -588.23% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 1,503.35% -14.62% 367.63% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -350.31% 1.46% -229.04% -44.47% -66.23% -90.24% -106.11% -126.41% -147.56% -238.46% -241.16%
Cash Return on Invested Capital (CROIC)		 -147.27% -97.43% -117.14% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 -270.99% 1.31% -227.84% -363.79% -860.64% -19.00% -17.70% -13.39% -53.82% -46.22% -60.28%
Return on Assets (ROA)		 -287.20% 0.93% -229.88% -385.01% -943.66% -22.57% -20.98% -16.75% -73.12% -54.82% -81.80%
Return on Common Equity (ROCE)		 -350.31% 1.46% -229.04% -44.47% -66.23% -90.24% -106.11% -126.41% -147.56% -238.46% -241.16%
Return on Equity Simple (ROE_SIMPLE)		 -29.77% 0.00% -38.12% -52.86% -85.00% 0.00% -202.29% -293.18% -429.05% 0.00% -645.89%
Net Operating Profit after Tax (NOPAT)		 -42 27 -52 -46 -57 -43 -38 -31 -28 -32 -28
NOPAT Margin		 -2,875.27% 26.60% -975.03% -1,880.75% -4,073.48% -646.19% -447.37% -276.89% -1,231.29% -614.43% -1,756.97%
Net Nonoperating Expense Percent (NNEP)		 -1.51% -5.71% -8.45% -5.15% -7.63% -7.95% -9.06% -5.58% -3.55% -9.88% -3.97%
Return On Investment Capital (ROIC_SIMPLE)		 - 4.52% - - - -12.80% - - - -71.97% -32.28%
Cost of Revenue to Revenue		 0.00% 1.22% 0.00% 0.00% 0.00% 0.97% 1.77% 2.10% 11.54% 11.86% 12.57%
SG&A Expenses to Revenue		 933.26% 17.96% 339.23% 883.98% 1,300.78% 276.65% 167.01% 143.83% 589.86% 259.84% 821.12%
R&D to Revenue		 3,317.32% 56.77% 1,141.95% 1,900.74% 4,648.19% 637.15% 479.58% 302.49% 1,337.78% 743.92% 2,306.32%
Operating Expenses to Revenue		 4,207.52% 72.99% 1,492.90% 2,786.79% 5,919.26% 1,022.16% 737.34% 493.46% 1,847.44% 965.91% 2,597.38%
Earnings before Interest and Taxes (EBIT)		 -45 9.53 -77 -65 -82 -62 -55 -45 -33 -62 -32
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -43 12 -75 -63 -84 -62 -56 -45 -31 -60 -30
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.08 2.23 2.29 1.54 1.19 1.56 1.69 2.24 4.30 0.00 17.02
Price to Tangible Book Value (P/TBV)		 2.55 2.71 2.89 2.04 1.73 2.68 4.02 14.18 0.00 0.00 0.00
Price to Revenue (P/Rev)		 14.27 9.97 8.60 4.87 2.86 20.43 13.08 7.85 8.40 31.74 28.38
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 5.27 3.76 3.34 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 9.15 7.49 6.92 0.41 0.00 0.00 0.00 0.00 0.00 19.07 9.28
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.37 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.30 0.27 0.32 0.36 0.48 0.63 0.88 1.34 1.44 -7.60 1.53
Long-Term Debt to Equity		 0.24 0.22 0.25 0.29 0.38 0.49 0.70 1.06 0.92 -7.60 1.53
Financial Leverage		 -0.81 -0.67 -0.63 -1.06 -1.22 -1.10 -1.09 -2.03 -2.82 -4.15 -4.50
Leverage Ratio		 1.40 1.41 1.45 1.96 2.19 2.25 2.50 3.72 4.67 6.91 7.62
Compound Leverage Factor		 1.49 0.98 1.48 2.07 2.40 2.56 2.94 4.57 6.36 8.10 10.23
Debt to Total Capital		 23.02% 21.29% 24.02% 26.71% 32.28% 38.49% 46.92% 57.35% 59.01% 115.15% 60.50%
Short-Term Debt to Total Capital		 4.30% 4.30% 5.02% 5.74% 6.73% 8.36% 9.98% 12.32% 21.47% 0.00% 0.00%
Long-Term Debt to Total Capital		 18.72% 17.00% 19.01% 20.97% 25.55% 30.14% 36.94% 45.02% 37.54% 115.15% 60.50%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 76.98% 78.71% 75.98% 73.29% 67.72% 61.51% 53.08% 42.65% 40.99% -15.15% 39.50%
Debt to EBITDA		 -1.16 -1.19 -0.93 -0.77 -0.61 -0.46 -0.49 -0.53 -0.41 -0.27 -0.31
Net Debt to EBITDA		 2.89 2.43 1.32 2.99 2.53 1.73 1.61 1.59 1.96 1.78 2.32
Long-Term Debt to EBITDA		 -0.94 -0.95 -0.74 -0.60 -0.48 -0.36 -0.39 -0.41 -0.26 -0.27 -0.31
Debt to NOPAT		 -1.07 -1.29 -1.14 -1.07 -0.94 -0.66 -0.70 -0.77 -0.57 -0.40 -0.44
Net Debt to NOPAT		 2.68 2.64 1.62 4.14 3.90 2.48 2.31 2.33 2.73 2.66 3.25
Long-Term Debt to NOPAT		 -0.87 -1.03 -0.90 -0.84 -0.74 -0.51 -0.55 -0.61 -0.36 -0.40 -0.44
Altman Z-Score		 1.75 2.50 1.63 0.24 -0.31 -0.58 -0.88 -1.06 -1.44 -1.49 -1.46
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 7.26 6.28 6.67 11.07 10.11 8.85 9.39 7.36 6.51 9.74 11.99
Quick Ratio		 6.94 6.00 6.33 10.70 9.63 8.44 8.92 6.61 6.18 9.32 11.33
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -65 -44 -148 197 311 451 469 140 37 36 45
Operating Cash Flow to CapEx		 -1,229.39% -1,079.35% -3,343.38% -5,306.98% 2,288.88% -2,430.86% -2,584.26% -5,415.73% -9,631.05% -132,110.00% -35,000.00%
Free Cash Flow to Firm to Interest Expense		 -21.07 -12.88 -41.62 28.87 20.17 28.72 29.15 8.64 2.24 2.41 3.00
Operating Cash Flow to Interest Expense		 -15.96 -15.96 -21.98 -8.33 2.52 -3.15 -3.76 -2.02 -2.20 -3.55 -2.92
Operating Cash Flow Less CapEx to Interest Expense		 -17.26 -17.44 -22.64 -8.49 2.41 -3.28 -3.91 -2.06 -2.23 -3.56 -2.93
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.09 0.14 0.16 0.14 0.15 0.02 0.03 0.03 0.04 0.04 0.03
Accounts Receivable Turnover		 16.66 1.32 1.53 2.12 42.65 0.30 0.33 0.50 8.21 5.38 3.05
Inventory Turnover		 0.00 0.00 0.00 0.19 0.13 0.01 0.03 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 1.38 2.26 2.32 2.37 2.39 0.33 0.40 0.74 0.80 0.81 0.65
Accounts Payable Turnover		 0.28 0.19 0.13 0.13 0.19 0.01 0.03 0.07 0.13 0.18 0.25
Days Sales Outstanding (DSO)		 21.91 276.18 237.94 172.29 8.56 1,227.60 1,109.33 727.24 44.47 67.79 119.60
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 1,915.38 2,871.25 53,200.15 12,859.03 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 1,313.33 1,962.68 2,736.77 2,823.51 1,913.78 49,331.15 11,982.19 5,601.00 2,821.97 1,989.64 1,458.19
Cash Conversion Cycle (CCC)		 -1,291.42 -1,686.49 -2,498.83 -735.84 966.03 5,096.60 1,986.18 -4,873.76 -2,777.50 -1,921.84 -1,338.59
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 107 212 228 -146 -262 -282 -279 -317 -327 -350 -352
Invested Capital Turnover		 0.64 0.60 0.61 -4.48 -1.44 -0.45 -0.74 -0.12 -0.10 -0.09 -0.06
Increase / (Decrease) in Invested Capital		 23 71 96 -243 -369 -494 -507 -170 -65 -68 -73
Enterprise Value (EV)		 562 797 761 46 -211 -166 -177 -176 -143 517 188
Market Capitalization		 877 1,061 946 545 320 324 249 218 240 861 573
Book Value per Share		 $9.01 $10.17 $8.79 $7.43 $5.63 $4.34 $3.03 $2.00 $1.15 ($0.14) $0.62
Tangible Book Value per Share		 $7.36 $8.37 $6.96 $5.62 $3.89 $2.53 $1.28 $0.32 ($0.92) ($2.06) ($1.14)
Total Capital		 547 605 543 482 397 338 276 228 136 45 85
Total Debt		 126 129 131 129 128 130 130 131 80 51 52
Total Long-Term Debt		 102 103 103 101 101 102 102 103 51 51 52
Net Debt		 -314 -264 -185 -500 -531 -490 -426 -394 -383 -344 -386
Capital Expenditures (CapEx)		 3.99 5.07 2.34 1.07 1.70 2.04 2.34 0.60 0.38 0.04 0.13
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -16 74 88 88 -7.19 -12 4.43 15 -13 -17 -9.90
Debt-free Net Working Capital (DFNWC)		 424 427 404 716 652 606 560 540 422 350 399
Net Working Capital (NWC)		 401 401 376 689 625 578 533 512 393 350 399
Net Nonoperating Expense (NNE)		 6.19 21 25 23 32 30 28 25 16 41 16
Net Nonoperating Obligations (NNO)		 -314 -264 -185 -500 -531 -490 -426 -414 -383 -344 -386
Total Depreciation and Amortization (D&A)		 2.10 2.33 1.60 1.68 -2.10 -0.20 -1.07 -0.31 1.19 1.93 2.41
Debt-free, Cash-free Net Working Capital to Revenue		 -26.33% 69.49% 80.19% 78.33% -6.42% -72.61% 23.33% 54.61% -45.98% -63.74% -49.01%
Debt-free Net Working Capital to Revenue		 690.46% 400.85% 366.82% 639.86% 582.42% 3,827.49% 2,947.52% 1,947.38% 1,476.54% 1,291.48% 1,975.70%
Net Working Capital to Revenue		 652.14% 376.45% 342.05% 615.15% 558.56% 3,649.42% 2,802.35% 1,846.10% 1,374.28% 1,291.48% 1,975.70%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($1.02) $0.15 ($1.63) ($1.44) ($1.88) ($1.52) ($1.36) ($1.16) ($0.91) ($1.49) ($0.82)
Adjusted Weighted Average Basic Shares Outstanding		 46.77M 46.74M 47.44M 47.65M 47.77M 47.67M 48.38M 48.62M 48.72M 48.65M 53.11M
Adjusted Diluted Earnings per Share		 ($1.02) $0.15 ($1.63) ($1.44) ($1.88) ($1.52) ($1.36) ($1.16) ($0.91) ($1.49) ($0.82)
Adjusted Weighted Average Diluted Shares Outstanding		 46.77M 46.74M 47.44M 47.65M 47.77M 47.67M 48.38M 48.62M 48.72M 48.65M 53.11M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 46.82M 46.98M 47.58M 47.70M 47.81M 47.84M 48.55M 48.70M 48.74M 54.08M 54.75M
Normalized Net Operating Profit after Tax (NOPAT)		 -42 19 -52 -46 -57 -43 -38 -31 -28 -32 -28
Normalized NOPAT Margin		 -2,875.27% 18.05% -975.03% -1,880.75% -4,073.48% -646.19% -447.37% -276.89% -1,231.29% -614.43% -1,756.97%
Pre Tax Income Margin		 -3,325.47% 6.42% -1,472.94% -2,820.44% -6,371.00% -1,049.07% -765.61% -497.49% -1,941.80% -1,386.80% -2,753.10%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -14.71 2.78 -21.49 -9.46 -5.29 -3.92 -3.44 -2.79 -1.97 -4.15 -2.13
NOPAT to Interest Expense		 -13.58 7.98 -14.58 -6.66 -3.71 -2.75 -2.36 -1.91 -1.70 -2.16 -1.82
EBIT Less CapEx to Interest Expense		 -16.01 1.30 -22.15 -9.62 -5.40 -4.05 -3.59 -2.82 -1.99 -4.15 -2.14
NOPAT Less CapEx to Interest Expense		 -14.87 6.50 -15.23 -6.82 -3.82 -2.88 -2.50 -1.94 -1.72 -2.16 -1.83
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Key Financial Trends

uniQure’s Q1 2025 results show continued investment in R&D and a strong cash runway but persistent revenue weakness and ongoing cash burn.

  • Strong liquidity with $217 M in cash and $192 M in short-term investments at end of Q1 2025, supporting operations through anticipated clinical milestones.
  • Free cash flow to firm rose to $45.3 M in Q1 2025 from $35.9 M in Q4 2024, indicating improved cash conversion from investing and financing activities.
  • Net loss narrowed to $43.6 M in Q1 2025 versus $65.6 M in Q1 2024, reflecting lower operating expenses relative to prior year.
  • R&D expense remained elevated at $36.1 M (23.1% of revenue) in Q1 2025, underscoring commitment to gene therapy pipelines despite near-term losses.
  • Current ratio of 11.99× and quick ratio of 11.33× in Q1 2025 point to ample liquidity but also a small revenue base to absorb expenses.
  • Revenue plunged 81.5% year-over-year to $1.57 M in Q1 2025 and was down 70% sequentially, highlighting volatility in program-related income.
  • Operating cash flow remained deeply negative at –$44.1 M in Q1 2025, showing ongoing cash burn from R&D and SG&A activities.
  • Operating loss margin widened to –25.1% in Q1 2025 as total operating expenses of $40.7 M far exceeded revenues.
  • Profit margin deteriorated to –27.8% in Q1 2025 from –14.0% in Q4 2024, underscoring challenges in containing losses.
  • Price-to-revenue multiple rose to 28.4× in Q1 2025 despite revenue decline, indicating high valuation that may be sensitive to clinical readouts.
07/17/25 11:30 AMAI Generated. May Contain Errors.

Frequently Asked Questions About uniQure's Financials

When does uniQure's financial year end?

According to the most recent income statement we have on file, uniQure's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has uniQure's net income changed over the last 10 years?

uniQure's net income appears to be on an upward trend, with a most recent value of -$239.56 million in 2024, rising from -$49.78 million in 2014. The previous period was -$308.48 million in 2023. Check out uniQure's forecast to explore projected trends and price targets.

What is uniQure's operating income?
uniQure's total operating income in 2024 was -$184.29 million, based on the following breakdown:
  • Total Gross Profit: $25.85 million
  • Total Operating Expenses: $210.15 million
How has uniQure's revenue changed over the last 10 years?

Over the last 10 years, uniQure's total revenue changed from $6.14 million in 2014 to $27.12 million in 2024, a change of 341.6%.

How much debt does uniQure have?

uniQure's total liabilities were at $563.29 million at the end of 2024, a 9.7% decrease from 2023, and a 318.1% increase since 2015.

How much cash does uniQure have?

In the past 9 years, uniQure's cash and equivalents has ranged from $132.50 million in 2016 to $556.26 million in 2021, and is currently $158.93 million as of their latest financial filing in 2024.

How has uniQure's book value per share changed over the last 10 years?

Over the last 10 years, uniQure's book value per share changed from 0.00 in 2014 to -0.14 in 2024, a change of -13.9%.


Related Companies

This page (NASDAQ:QURE) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...
Paradigm Press | Sponsored
[No Brainer Gold Play]: “Show me a better investment.”
A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...
Golden Portfolio | Sponsored
The DOJ Just Paved the Way for Account Seizures
Washington is running out of money…And guess where they'll look next? When governments go broke, they take ...
Priority Gold | Sponsored
Google did what!?!?
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...
Stansberry Research | Sponsored
$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...
Brownstone Research | Sponsored